YD Bio Limited
YDESNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $477.38M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.70$22.00
- Volume (live)
- -
- Avg. volume (3M)
- 502.64K
YD Bio (YDES) Stock Price & Financial Analysis
YD Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.82 - $7.05 |
|---|---|
| 52-Week High | $22.00 |
| 52-Week Low | $1.70 |
| Open | $6.67 |
| Volume (last close) | 153.37K |
| Average Volume (3M) | 502.64K |
| Revenue (TTM) | 1.24M |
|---|---|
| Net Income (TTM) | -11.98M |
| Free Cash Flow (TTM) | -8.70M |
| EPS (TTM) | −$0.18 |
| Profit Margin | -966.42% |
| Operating Margin | -327.67% |
| Return on Equity (ROE) | -267.70% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 477.38M |
|---|---|
| Shares Outstanding | 70.83M |
| Price to Sales (P/S) | 385.20 |
| Price to Book (P/B) | 106.70 |
| EV/EBITDA | -74.85 |
| 50-Day MA | $4.48 |
|---|---|
| 200-Day MA | $5.90 |
| 1-Year Change | −66.45% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
YD Bio at a Glance
As of the Oct 16, 2026 close, YD Bio (YDES) has a market capitalization of $477.38M. The stock trades at 385.2× sales. Over the trailing twelve months it lost $11.98M on revenue of $1.24M and burned $8.70M of free cash flow. Revenue grew 257.5% year over year.
As of its latest reported balance sheet, it holds $2.66M in cash and securities against $6.76K of debt, a net cash position of $2.66M.
YD Bio does not currently pay a dividend.
The share price is down 66.5% over the past year. At $5.92 (the Oct 16, 2026 close) it sits within its 52-week range of $1.70 to $22.00, above its 200-day moving average of $5.90.
Frequently Asked Questions About YD Bio
What is the current stock price for YDES?
As of the Oct 16, 2026 close, YDES stock trades at $5.92. The 52-week range is $1.70–$22.00, with a day range of $5.82–$7.05.
What is the P/E ratio for YDES?
The P/E ratio (Price-to-Earnings) for YDES is shown in the Key Statistics section. This valuation metric helps compare YD Bio Limited to industry peers.
Does YDES pay dividends?
YD Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for YDES?
Analyst ratings and recommendations for YDES are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of YDES?
As of the Oct 16, 2026 close, YD Bio's market capitalization is $419.3M, classifying it as a small-cap company. YD Bio operates in the Healthcare sector within the Biotechnology industry.